Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
AYTU
#3661
AYTU BioPharma, Inc. Common Stock
2.5
7
+3.21%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+3.21%
Monthly Change
-3.02%
6 month change
+7.98%
Year Change
+102.36%
Previous Close
2.4
9
Open
2.5
7
Bid
Ask
Low
2.5
7
High
2.5
7
Volume
1
Markets
US Stock Market
Healthcare
AYTU
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
2020
2021
2022
2023
2024
TTM
Cash from operating activities
26 M
28.8 M
5.1 M
1.39 M
1.94 M
3.28 M
Cash from investing activities
2.78 M
3.25 M
117 K
329 K
2.56 M
2.05 M
Cash from financing activities
30.31 M
1.53 M
8.87 M
1.26 M
15.44 M
17.56 M
Free cash flow
26 M
28.8 M
5.1 M
1.39 M
-1.29 M
3.26 M
News
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript
Aytu BioPharma Inc. (AYTU) Reports Q2 Loss, Beats Revenue Estimates
Earnings call transcript: Aytu BioPharma Q2 2026 sees revenue dip, stock falls
New Strong Sell Stocks for February 2nd
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day - Slideshow (NASDAQ:AYTU) 2026-01-20
Aytu launches EXXUA, first selective 5-HT1A agonist for depression
Aytu BioPharma stock rises after commercial launch of depression drug EXXUA
Aytu BioPharma launches depression drug EXXUA in U.S. market
Ascendiant Capital raises Aytu Biosciences stock price target on Q1 beat
Aytu BioPharma, Inc. (AYTU) Q1 2026 Earnings Call Transcript
Earnings call transcript: Aytu BioPharma’s Q1 2025 shows stable stock